Next Article in Journal
Comparison of In-Solution Biorecognition Properties of Aptamers against Ochratoxin A
Next Article in Special Issue
Fast Screening of Antibacterial Compounds from Fusaria
Previous Article in Journal
Detoxification of Deoxynivalenol via Glycosylation Represents Novel Insights on Antagonistic Activities of Trichoderma when Confronted with Fusarium graminearum
Previous Article in Special Issue
Determination of Deoxynivalenol in the Urine of Pregnant Women in the UK
Article Menu
Issue 11 (November) cover image

Export Article

Open AccessArticle
Toxins 2016, 8(11), 334; doi:10.3390/toxins8110334

Deoxynivalenol and Its Modified Forms: Are There Major Differences?

Division of Veterinary Pharmacology, Pharmacotherapy and Toxicology, Institute for Risk Assessment Sciences, Utrecht University, Yalelaan 104, 3584-CM Utrecht, The Netherlands
Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584-CG Utrecht, The Netherlands
Department Immunology, Nutricia Research, Uppsalalaan 12, 3584-CT Utrecht, The Netherlands
Author to whom correspondence should be addressed.
Academic Editor: Sven Dänicke
Received: 4 July 2016 / Revised: 31 October 2016 / Accepted: 8 November 2016 / Published: 16 November 2016
(This article belongs to the Collection Fusarium Toxins – Relevance for Human and Animal Health)
View Full-Text   |   Download PDF [3633 KB, uploaded 16 November 2016]   |  


Considering the diverse toxic effects of the Fusarium toxin deoxynivalenol (DON), its common occurrence in wheat-based products, and its stability during processing, DON constitutes an increasing health concern for humans and animals. In addition to the parent compound DON, human and animal exposure encompasses the acetylated fungal metabolites 3-acetyl-deoxynivalenol (3ADON) and 15-acetyl-deoxynivalenol (15ADON) as well as the plant-derived DON-glucoside (DON3G) and the bacterial product de-epoxy-DON (DOM-1). In the current study we used the well-established Caco-2 cell model to compare the effects of these naturally occurring forms of DON on cell viability and markers of barrier integrity, as well as on the release of the pro-inflammatory chemokine chemokine CXC motif ligand (CXCL8). Results show that 3ADON is less potent in inducing adverse effects on barrier integrity when compared to DON, whereas 15ADON appears to be slightly more potent than DON. In contrast, DON3G and DOM-1 exerted no measurable adverse effects on the intestinal barrier. It was also demonstrated that galacto-oligosaccharides (GOS) are able to protect epithelial cells against DON and its acetylated forms, which suggests that GOS are beneficial food additives in the protection of vulnerable segments of the human population against adverse effects of DON and its derivatives. View Full-Text
Keywords: mycotoxin; deoxynivalenol; 3-acetyl-deoxynivalenol; 15-acetyl-deoxynivalenol; de-epoxy-DON; DON-3-O-glucoside; intestinal barrier; CXCL8 mycotoxin; deoxynivalenol; 3-acetyl-deoxynivalenol; 15-acetyl-deoxynivalenol; de-epoxy-DON; DON-3-O-glucoside; intestinal barrier; CXCL8

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Alizadeh, A.; Braber, S.; Akbari, P.; Kraneveld, A.; Garssen, J.; Fink-Gremmels, J. Deoxynivalenol and Its Modified Forms: Are There Major Differences? Toxins 2016, 8, 334.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top